RICERCA
AUTORI
RIVISTE
Sfoglia per AUTORE
PUOTI M
Collezione ASL Città di Torino
Items : 19
Safety and efficacy of daclatasvir at doses other than 60?mg daily in HIV/HCV co-infected subjects: Data from the ICONA/HepaICONA foundation cohorts. in Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver / Dig Liver Dis. 2020 Apr;52(4):447-451. doi: 10.1016/j.dld.2019.12.007. Epub 2020 Jan 17.
2020
ASL Città di Torino
Bonora S; Tavelli A; Rossotti R; Cingolani A; Lo Caputo S; Saracino A; Soria A; Marinaro L; Uberti-Foppa C; Mussini C; Puoti M; d'Arminio Monforte A;
VIRONET-C real life experience of resistance-guided retreatment in HCV infected patients who previously failed a NS5A inhibitor-containing regimen in Digestive and Liver Disease
2020
ASL Città di Torino
Ceccherini-Silberstein F; Craxì A; Perno CF; Angelico M; Andreoni M; Zazzi M; Raimondo G; Puoti M; Gaeta GB; Baldanti F; Coppola N; Parruti G; Lampertico P; Ghisetti V; Beretta I; Cariti G; Rossetti B; Lleo A; Dentone C; Sighinolfi L; Giorgini A; Di Lorenzo F; Licata A; Mastroianni C; Milano E; Pellicelli A; Giannelli V; Rizzardini G; Ganga R; et alii...
Is physician assessment of alcohol consumption useful in predicting risk of severe liver disease among people with HIV and HIV/HCV co-infection? in BMC public health / BMC Public Health. 2019 Oct 15;19(1):1291. doi: 10.1186/s12889-019-7608-1.
2019
ASL Città di Torino
Lampe FC; Caramello P; Caterina UF; Sighinolfi L; De Luca A; Puoti M; Girardi E; Shanyinde M; D'Arminio Monforte A; Cozzi-Lepri A;
Impact of diabetes on the risk of serious liver events and liver-related deaths in people living with HIV and hepatitis C co-infection: data from the ICONA Foundation Cohort Study. in European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology / Eur J Clin Microbiol Infect Dis. 2019 Oct;38(10):1857-1865. doi: 10.1007/s10096-019-03618-8. Epub 20
2019
ASL Città di Torino
Leone S; Lorenzini P; Cozzi-Lepri A; Orofino G; Bernacchia D; Castagna A; Menozzi M; Guaraldi G; Madeddu G; Di Biagio A; Puoti M; Gori A; d'Arminio Monforte A;
Sustained virological response with 16-week glecaprevir/pibrentasvir after failure to sofosbuvir/velpatasvir in post-transplant severe HCV recurrence in HIV. in Transplant infectious disease : an official journal of the Transplantation Society / Transpl Infect Dis. 2019 Dec;21(6):e13165. doi: 10.1111/tid.13165. Epub 2019 Sep 15.
2019
ASL Città di Torino
De Carlis L; Bargiacchi O; Alcantarini C; Angelini Zucchetti T; Lauterio A; Ferla F; Travi G; Rossotti R; Merli M; Puoti M;
Resistance-guided retreatment of HCV infected patients with a previous failure to an NS5A inhibitor-containing regimen: Italian real life experience in Journal of Hepatology
2019
ASL Città di Torino
Francesca Ceccherini S; Mario A; Federico Perno C; Andreoni M; Craxi A; Raimondo G; Zazzi M; Nicola C; Parruti G; Pellicelli A; Lampertico P; Rizzardini G; Ganga R; Puoti M; Paternoster C; Taliani G; Santantonio T; Babudieri S; De Santis A; Lichtner M; Cozzolongo R; Brunetto M; Borghi V; Rita Maida I; Morsica G; Sangiovanni V; Cuomo N; Ciancio A; Andreone P; et alii...
Resistance test guided retreatment of HCV infected patients with a previous failure to a NS5A inhibitor-containing regimen: the Italian Vironet C real life experience in Digestive and Liver Disease
2019
ASL Città di Torino
Ceccherini-Silberstein F; Perno CF; Craxì A; Angelico M; Andreoni M; Raimondo G; Zazzi M; Coppola N; Parruti G; Giorgini A; Lampertico P; Di Lorenzo F; Licata A; Mastroianni C; Milano E; Pellicelli A; Rizzardini G; Ganga R; Puoti M; Paternoster C; Santantonio T; Di Stefano M; Taliani G; Babudieri S; Lichtner M; De Santis A; Cozzolongo R; Colombatto P; Brunetto M; et alii...
Characterization of baseline factors associated with treatment outcome in HCV-infected patients naive to direct acting antivirals: particular focus on natural resistance in Digestive and Liver Disease
2019
ASL Città di Torino
Perno CF; Ceccherini-Silberstein F; Craxì A; Andreoni M; Baldanti F; Angelico M; Pasquazzi C; Parruti G; Lampertico P; Taliani G; Babudieri S; Rizzardini G; Pellicelli A; Puoti M; Paba P; Sarmati L; Borghi V; Lichtner M; Guarneri V; Siciliano M; Morisco F; Iapadre N; Maserati R; Bonora S; Micheli V; Boccaccio V; Galli S; Magni CF; Campoli R; et alii...
Evaluation of risk factors associated with failure to a first-line NS5A-containing regimen in HCV-infected patients naive to direct acting antivirals: Particular focus on natural resistance in Journal of Hepatology
2019
ASL Città di Torino
Silberstein FC; Perno CF; Mario A; Andreoni M; Parruti G; Pasquazzi C; Lampertico P; Taliani G; Rizzardini G; Babudieri S; Pellicelli A; Craxi A; Sarmati L; Puoti M; Paba P; Lichtner M; Andreone P; Siciliano M; Morisco F; Bonora S; Iapadre N; Maserati R; Boccaccio V; Micheli V; Galli S; Magni CF; Campoli R; Borghi V; Nicolini LA; et alii...
Evaluation of risk factors associated with failure to a first-line NS5A-containing regimen in HCV-infected patients naive to direct acting antivirals: Particular focus on natural resistance in Journal of Hepatology
2019
ASL Città di Torino
Ceccherini Silberstein F; Federico Perno C; Andreoni M; Mario A; Parruti G; Pasquazzi C; Lampertico P; Taliani G; Rizzardini G; Pellicelli A; Babudieri S; Craxi A; Puoti M; Sarmati L; Paba P; Lichtner M; Andreone P; Siciliano M; Morisco F; Iapadre N; Bonora S; Maserati R; Boccaccio V; Micheli V; Federico Magni C; Galli S; Campoli R; Borghi V; Ambra Nicolini L; et alii...
Decline of prevalence of resistance associated substitutions to NS3 and NS5A inhibitors at DAA failure in hepatitis C virus in Italy over the years 2015 to 2018 in Hepatology v70 suppl.1 2019
2019
ASL Città di Torino
Silberstein FC; Zazzi M; Craxì A; Federico Perno C; Angelico M; Andreoni M; Rizzardini G; Raimondo G; Battista Gaeta G; Lampertico P; Babudieri S; Caudai C; Cuomo N; Santantonio TA; Pollicino T; Brunetto MR; Andreone P; Borghi V; Aghemo A; Ciancio A; Cariti G; Giorgini A; Palitti VP; Ciaccio A; Licata A; Lenci I; Biolato M; Sangiovanni V; Prestileo T; et alii...
Italian real life experience of resistanceguided retreatment in HCV infected patients who previously failed a NS5A inhibitor-containing regimen in Hepatology v70 suppl.1 2019
2019
ASL Città di Torino
Silberstein FC; Perno CF; Craxì A; Angelico M; Andreoni M; Zazzi M; Raimondo G; Coppola N; Parruti G; Lampertico P; Beretta I; Rossetti B; Lleo A; Dentone C; Sighinolfi L; Di Lorenzo F; Giorgini A; Licata A; Mastroianni C; Milano E; Pellicelli A; Rizzardini G; Ganga R; Puoti M; Paternoster C; Di Stefano M; Santantonio TA; Taliani G; Biliotti E; et alii...
Incidence and predictors of single drug discontinuation according to the presence of HCV coinfection in HIV patients from the ICONA Foundation Cohort Study. in European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology / Eur J Clin Microbiol Infect Dis. 2018 May;37(5):871-881. doi: 10.1007/s10096-017-3180-8. Epub 2018 J
2018
ASL Città di Torino
Leone S; Shanyinde M; Cozzi Lepri A; Lampe FC; Caramello P; Costantini A; Giacometti A; De Luca A; Cingolani A; Ceccherini Silberstein F; Puoti M; Gori A; d'Arminio Monforte A;
Current and future challenges in HCV: insights from an Italian experts panel. in Infection / Infection. 2018 Apr;46(2):147-163. doi: 10.1007/s15010-017-1093-1. Epub 2017 Nov 2.
2018
ASL Città di Torino
Andreoni M; Babudieri S; Bruno S; Colombo M; Zignego AL; Di Marco V; Di Perri G; Perno CF; Puoti M; Taliani G; Villa E; Craxì A;
Comparison of resistance profiles among DAA-naive and DAAexperienced patients infected with HCV non-1 genotype in Italy in Journal of Hepatology
2018
ASL Città di Torino
Silberstein FC; Cento V; Perno CF; Andreoni M; Angelico M; Sarmati L; Parruti G; Pasquazzi C; Craxi A; Gaeta GB; Raimondo G; Taliani G; Ciaccio A; Sangiovanni V; Rendina MG; Pellicelli A; Gubertini GA; Babudieri S; Bonora S; Boglione L; D'ambrosio R; Vullo V; Rossetti B; Zazzi M; Puoti M; Maserati R; Ciancio A; Boccaccio V; Lleo A; et alii...
Characterization of resistance profiles in HCV 2-3-4 DAA-naïve and DAA-experienced infected patients in Italy in Digestive and Liver Disease
2018
ASL Città di Torino
Ceccherini-Silberstein F; Perno CF; Cento V; Andreoni M; Angelico M; Parruti G; Sarmati L; Pasquazzi C; Craxì A; Gaeta GB; Raimondo G; Taliani G; Ciaccio A; Sangiovanni V; Pellicelli A; Rendina M; Gubertini G; Babudieri S; Bonora S; Boglione L; D'Ambrosio AR; Vullo V; Zazzi M; Rossetti B; Puoti M; Maserati R; Ciancio A; Boccaccio V; Lleo A; et alii...
Trend of estimated glomerular filtration rate during ombistasvir/paritaprevir/ritonavir plus dasabuvir ± ribavirin in HIV/HCV co-infected patients. in PloS one / PLoS One. 2018 Feb 20;13(2):e0192627. doi: 10.1371/journal.pone.0192627. eCollection 2018.
2018
ASL Città di Torino
AOU Città della Salute di Torino
Segala D; Teti E; Taramasso L; Di Biagio A; Bovis F; Nicolini LA; Antinori A; Milazzo L; Chirianni A; Vullo V; Parruti G; Giacometti A; Cacopardo B; Boffa N; Gori A; Spinetti A; Puoti M; Pasquazzi C; Di Perri G; Mastroianni C; Bruno R; Borghi V; Montagnani F; Cattelan A; Hasson H; Taliani G; D'Arminio Monforte A; Bigoni S; Saracino A; et alii...
Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir Combination Treatment in Patients with HIV/HCV Co-Infection: Results of an Italian Compassionate Use Program. in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America / Clin Infect Dis. 2017 Mar 1;64(5):680-683. doi: 10.1093/cid/ciw846. Epub 2016 Dec 22.
2017
ASL Città di Torino
AOU Città della Salute di Torino
Massimo A; Teti E; Pasquazzi C; Pennica A; Chirianni A; Vullo V; Parruti G; Giacometti A; Bruno C; Boffa N; Gori A; Spinetti A; Puoti M; Bigoni S; Di Perri G; Mastroianni CM; Monforte AD; Taliani G; Hasson H; Cattelan A; De Luca A; Borghi V; Saracino A; Bruno R; Di Biagio A; Rizzardini G; Sollima S; Milazzoi L; Antinori A; et alii...
2017
ASL Città di Torino
Craxi A; Taliani G; Raimondo G; Ciaccio A; Sangiovanni V; Cariti G; Bonora S; Aghemo A; Vullo V; Foroghi L; Calvaruso V; Morisco F; Lleo A; Ciancio A; Maserati R; Brancaccio G; Puoti M; Toniutto P; Pollicino T; Paolucci S; Coppola N; Ruggiero T; Bruzzone B; Palitti VP; Gianserra L; Polilli E; Teti E; Lenci I; Aragri M; et alii...